About 2,190 results
Targeted Oncology - Immunotherapy, Biomarkers, and Cancer …
Adjuvant T-DM1 Continues to Outperform Trastuzumab in HER2 …
Managing Chemotherapy Toxicities for Improved Patient Outcomes
Continuing Osimertinib Treatment After Progression Prolongs …
High-Dose Radiation Plus Long-Term ADT Improves Survival in …
Breast Cancer | Oncology News & Insights | Targeted Oncology
Defining Unresectable and Advanced HCC - Targeted Oncology
Recent Approvals Signal a Bright Future for Myelodysplastic …
FDA Accepts Nivolumab/Ipilimumab Application for First-Line HCC …
FDA Grants Breakthrough Therapy Designation to SNDX-5613 for …